ArticleHeliyon2019
Antioxidant and nephroprotection activities of
Article in Heliyon, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed, 59 citations in OpenAlex.
- Ethanolic Extract of Kinkeliba (International journal of molecular sciences · 2025Article
- How to assess antioxidant activity? Advances, limitations, and applications of in vitro, in vivo, and ex vivo approaches.Food production, processing and nutrition · 2025Review
- Anti-cholinesterase, anti-inflammatory and antioxidant properties ofIBRO neuroscience reports · 2023Article
- Antioxidant and Antibacterial Activities of the Leaf and Stem Extracts ofPlants (Basel, Switzerland) · 2023Article
- Phytochemical Composition ofPlants (Basel, Switzerland) · 2023Article
- Anti-fertility effect ofInternational journal of reproductive biomedicine · 2023Article
- Multi-Mechanistic and Therapeutic Exploration of Nephroprotective Effect of Traditional Ayurvedic Polyherbal Formulation Using In Silico, In Vitro and In Vivo Approaches.Biomedicines · 2023Article
- Metabolite Profiling and Nephroprotective Potential of theACS omega · 2022Article
- Antidiabetic Activity of Mung Bean orEvidence-based complementary and alternative medicine : eCAM · 2022Article
- Hypertension treatment with Combretum micranthum or Hibiscus sabdariffa, as decoction or tablet: a randomized clinical trial.Journal of human hypertension · 2021Review
- Parameter Optimization and Potential Bioactivity Evaluation of a Betulin Extract from White Birch Bark.Plants (Basel, Switzerland) · 2020Article
- Acute and subchronic oral toxicity assessments ofToxicology reports · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors at 4 institutions in 3 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Management of chronic renal failure is exceedingly expensive. Despite of encouraging experimental outcomes, there is a lack of potent nephroprotective drugable molecules in a clinics or market. To develop a nephroprotective phytomedicine, the present study was designed to do a literature survey on reported phytochemical and biological analysis of
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.